Results 1 to 5 of 7

Following the Patent Dance Three Years After Sandoz

USA - May 28 2019 In June 2017, the Supreme Court handed down its decision in Sandoz v. Amgen—the first lawsuit brought under the Biologics Price Competition and…

Drew Christie

Inherency in Obviousness—A Worrying Trend?

USA - April 13 2018 Anticipation by inherency is a well-recognized, and generally well-understood, patent law doctrine. A prior art reference may anticipate an…

Paul W. Browning Ph.D., Paul Townsend

CAFC and SCOTUS Take First Look at Provisions of BPCIA in Amgen v. Sandoz

USA - January 12 2018 In Amgen Inc. v. Sandoz Inc., 794 F.3d 1347 (Fed. Cir. 2015), the CAFC affirmed the district court’s interpretation of the “information exchange”…

Li Feng Ph.D.

“A riddle wrapped in a mystery inside an enigma”: the Federal Circuit attempts to decode the BPCIA

USA - July 27 2015 On July 21, 2015, the Federal Circuit issued a divided decision in Amgen Inc. v. Sandoz Inc., No. 15-1499 (Fed. Cir. July 21, 2015), interpreting two…

Jonathan R. Davies

Federal Circuit decision in Ariosa v. Sequenom offers further clarification on the scope of patent-eligible subject matter

USA - June 23 2015 On June 12, 2015, the Federal Circuit issued its eagerly anticipated decision in Ariosa v. Sequenom, which assessed the subject matter eligibility of…

Jeffrey M. Jacobstein, Alissa K. Lipton